Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B

Clinical trial NCT01926288 · COMPLETED

Trial details

NCT number: NCT01926288
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2008-10-01
Primary completion: 2014-03-01
Enrollment: 287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.